Insider Trading & Ownership of Samsara BioCapital, L.P.

Location: Palo Alto, CA
Summary: The estimated value of insider holdings of Samsara BioCapital, L.P. is at least $34,668,033 dollars as of 13 Apr 2022. Samsara BioCapital, L.P. is the 10%+ Owner of Graphite Bio, Inc. and owns shares of LENZ Therapeutics, Inc. (LENZ) stock worth about $34.67M.
Signature: Samsara BioCapital, L.P., By: Samsara BioCapital GP, LLC, its General Partner, By /s/ Srinivas Akkaraju, Managing Member
All Insider Reports: All Insider Reports

Notify me when Samsara BioCapital, L.P. files a new Insider Trading report.

Ownership of Samsara BioCapital, L.P.

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
LENZ	Graphite Bio, Inc.	10%+ Owner	$34,668,033			11 Apr 2022

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.